Miscellaneous and General
I147 Index.
The expressions listed in the left-hand column below are respectively defined or (as the case may be) are to be interpreted in accordance with the provisions of this Act listed in the right-hand column in relation to those expressions.
Activities governed by this Act | Section 4(5) |
F22Appeals committee | F22Section 20A(2) |
Authority | Section 2(1) |
F1Basic partner treatment services | Section 2(1) |
Carry, in relation to a child | Section 2(3) |
F25. . . | F25. . . |
Directions | Section 2(1) |
F2Distribution, in relation to gametes or embryos intended for human application | Section 2(1) |
Embryo F19(except in section 4A or in the term “human admixed embryo”) | Section 1 |
F3First Directive | Section 1A |
F24Fourth Directive | Section 1A |
Gametes, eggs or sperm F20(except in section 4A) | Section 1 |
F22Human admixed embryo | F22Section 4A(6) |
F4Human application | Section 2(1) |
F24Importing licensee | Section 2B(2 |
Keeping, in relation to embryos or gametes | Section 2(2) |
Licence | Section 2(1) |
F23. . . | F23. . . |
F23. . . | F23. . . |
F5Non-medical fertility services | Section 2(1) |
F22Nuclear DNA (in relation to an embryo) | F22Section 2(1) |
F6Partner-donated sperm | Section 1(5) |
Person responsible | Section 17(1) |
Person to whom a licence applies | Section 17(2) |
F7Person to whom a third party agreement applies | Section 2A(3) |
F8Processing, in relation to gametes or embryos intended for human application | Section 2(1) |
F9Procurement, in relation to gametes or embryos intended for human application | Section 2(1) |
F24Qualifying gametes or embryos | Section 2B(3) |
F10Relevant third party premises, in relation to a licence | Section 2A(2) |
F11Second Directive | Section 1A |
F12Serious adverse event | Section 2(1) |
F13Serious adverse reaction | Section 2(1) |
F27. . . | F27. . . |
Store, and similar expressions, in relation to embryosF21, human admixed embryos or gametes | F14Section 2(1) |
F24Third country | Section 2B(4) |
F24Third country premises | Section 2B(5) |
F24Third country supplier | Section 2B(6) |
F15Third Directive | Section 1A |
F16Third party | Section 2A(2) |
F17Third party agreement | Section 2A(1) |
F26Tissue establishment | Section 2(1) |
F18Traceability | Section 2(1) |
Treatment services | Section 2(1) |